U.S. Markets closed
  • S&P Futures

    3,658.50
    +4.25 (+0.12%)
     
  • Dow Futures

    29,284.00
    -1.00 (-0.00%)
     
  • Nasdaq Futures

    11,239.25
    +11.00 (+0.10%)
     
  • Russell 2000 Futures

    1,683.60
    +1.50 (+0.09%)
     
  • Crude Oil

    81.57
    +0.34 (+0.42%)
     
  • Gold

    1,670.30
    +1.70 (+0.10%)
     
  • Silver

    18.81
    +0.09 (+0.50%)
     
  • EUR/USD

    0.9816
    -0.0003 (-0.0295%)
     
  • 10-Yr Bond

    3.7470
    +0.0420 (+1.13%)
     
  • Vix

    31.84
    +1.66 (+5.50%)
     
  • GBP/USD

    1.1148
    +0.0025 (+0.2207%)
     
  • USD/JPY

    144.6750
    +0.2320 (+0.1606%)
     
  • BTC-USD

    19,487.57
    -76.85 (-0.39%)
     
  • CMC Crypto 200

    445.25
    -0.73 (-0.16%)
     
  • FTSE 100

    6,881.59
    -123.80 (-1.77%)
     
  • Nikkei 225

    26,020.17
    -401.88 (-1.52%)
     

Britain approves Pfizer/BioNTech's updated COVID-19 booster vaccine

Sept 3 (Reuters) - Britain's medicines regulator on Saturday approved Pfizer/BioNTech's updated bivalent COVID-19 booster shot for people aged 12 years and older.

The Medicines and Healthcare products Regulatory Agency said the decision was based on data from a clinical trial that showed a booster dose with the bivalent Pfizer/BioNTech vaccine triggers a strong immune response against both the Omicron and the original strain. (Reporting by Shivam Patel in Bengaluru; Editing by Mike Harrison)